1280. Misbranding of Vin-Kre-Ol and Ba-Bow Corrective. U. S. v. 49 Bottles of Vin-Kre-01 and 1,575 Bottles of Ba-Bow Corrective. Consent decree of condemnation. Products ordered released under bond to be relabeled. (F. D. C. No. 12320. Sample Nos. 62468-F, 62469-F, 72143-F, 72144-F.) On or about May 5,1944, the United States attorney for the Eastern District of Arkansas filed a libel against the above-mentioned products at Blytheville, Ark., alleging that they had been shipped between the approximate dates of July 9,1943, and March 24, 1944, by Allan and Co., Inc., from St. Louis, Mo.; and charging that they were misbranded. Analysis of the Vin-Kre-01 showed that it consisted essentially of small pro- portions of compounds of calcium, iron, manganese, phosphorus, quinine, strych- nine, benzaldehyde, and guaiacol, and, sugar, alcohol, and water. The article was alleged to be misbranded because of false and misleading statements in the labeling which represented and suggested that it was effective as a palatable medicine and food for use in general debility or run-down conditions resulting from poor diet or nervous strain; and that it was effective for those recovering from illness or operations, and was an aid to natural recovery. Analysis of the Ba-Bow Corrective showed that it consisted essentially of compounds of bismuth and zinc, salol, volatile oils including oil of anise and methyl salicylate, gum, alcohol, and waster, colored with a pink dye. The article, was alleged to be misbranded because of the false and misleading statements in its labeling which represented and suggested that it was effective in the treat- ment or prevention of heartburn due to hyperacidity; and that it was a correc- tive, a baby bowel corrective, and was effective in such complaints of the stomach and bowels as the gastric fermentation and diarrhea caused by colitis, summer' complaint, and food upsets. On June 14, 1944, the Benz Medicine Co., Blytheville, Ark., having admitted the allegations of the libel, judgment of condemnation was entered and the articles were ordered released under bond to be relabeled under the supervision of the Food and Drug Administration.